TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SGRY

Surgery Partners Inc

Healthcare · Medical Care Facilities

14.40$ +1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Surgery Partners Inc (SGRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 8,050 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SGRY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,249 2,305 2,290 2,671 4,602 4,623 4,595 4,584 4,559 4,676 4,881 4,891 4,918 5,019 5,091 5,245 5,313 5,413 5,639 5,621 5,632 6,118 6,290 6,292 6,537 6,682 6,643 6,621 6,780 6,877 6,976 7,489 7,534 7,890 7,949 7,955 7,947 8,242 8,042 8,050
329 362 350 352 574 563 491 473 463 588 535 529 518 526 615 747 893 802 1,018 953 842 946 937 788 738 921 869 810 876 895 896 1,013 1,036 1,119 1,075 1,105 1,102 1,151 1,083 1,126
55 70 56 57 200 175 113 96 79 184 143 117 111 93 195 326 450 318 542 465 330 390 379 227 155 283 246 177 236 196 185 214 222 270 229 250 203 240 182 217
55 70 56 57 200 175 113 96 79 184 143 117 111 93 195 326 450 318 542 465 330 390 379 227 155 283 246 177 236 196 185 214 222 270 229 250 203 240 182 217
215 228 227 224 280 296 286 277 286 316 295 302 303 327 320 319 347 382 367 375 393 430 412 412 422 456 466 450 463 496 494 523 543 579 571 563 579 602 603 617
27 29 29 30 45 45 48 46 44 43 44 44 44 46 49 49 51 56 56 57 59 61 63 64 69 71 72 70 69 75 77 81 82 88 88 87 92 97 101 99
200 204 205 206 389 399 400 412 420 426 688 685 720 821 807 816 813 855 850 863 863 954 1,056 1,067 1,151 1,156 1,118 – – – – – – – – – – – – –
1,531 1,555 1,557 1,569 3,270 3,347 3,383 3,376 3,373 3,383 3,393 3,402 3,406 3,402 3,397 3,409 3,345 3,468 3,518 3,488 3,614 3,912 3,926 3,993 4,145 4,137 4,253 4,236 4,245 4,326 4,398 4,806 4,815 5,068 5,126 5,099 5,092 5,195 5,205 –
49 48 46 43 57 59 62 61 56 54 54 54 53 47 47 46 45 47 3,518 3,534 3,659 44 42 4,036 41 42 35 55 56 55 54 52 46 46 45 41 43 41 40 5,242
1,749 2,305 1,791 2,671 2,624 4,623 4,595 2,666 2,661 4,676 4,881 4,891 4,918 3,320 3,447 3,620 3,783 3,790 3,786 3,781 3,769 3,818 3,935 3,909 4,092 3,399 3,355 3,310 3,461 3,515 3,614 3,870 3,986 4,255 4,363 4,376 4,394 4,715 4,561 4,948
179 187 196 186 275 303 286 297 296 349 360 369 382 398 412 571 591 557 575 532 541 537 542 522 624 493 475 459 501 523 523 552 575 624 569 573 586 616 582 579
29 28 29 31 50 59 61 54 54 56 94 92 87 93 97 101 99 104 101 109 101 101 103 104 154 99 101 102 98 111 115 132 139 142 144 150 144 142 143 103
44 50 48 48 73 85 81 76 77 83 70 72 85 97 107 105 90 100 96 109 117 125 123 126 138 152 144 132 149 172 174 174 171 209 165 175 175 209 169 175
1,358 1,414 1,396 1,795 2,145 2,131 2,242 2,123 2,119 2,254 2,250 2,261 2,403 2,525 2,627 2,623 2,761 2,792 2,790 2,786 2,792 2,878 3,025 3,019 3,103 2,559 2,531 2,505 2,640 2,702 2,794 3,040 3,094 3,269 3,447 3,465 3,461 3,603 3,614 3,648
-8.3 9.7 8.2 6.3 1,022 655 631 941 922 405 391 359 329 692 641 619 525 550 776 765 756 1,089 1,161 1,155 1,173 1,998 1,962 2,018 2,005 1,987 1,967 1,952 1,897 1,790 1,740 1,748 1,730 1,713 1,688 1,671
-328 -311 -314 -319 -9.1 -41 -59 -78 -99 -247 -249 -269 -285 -316 -343 -376 -437 -432 -453 -480 -503 -503 -491 -509 -534 -557 -582 -563 -568 -569 -582 -597 -629 -737 -775 -778 -800 -815 -851 -866
48 48 48 48 49 48 48 48 48 48 48 48 48 48 48 49 49 49 55 69 81 85 90 89 89 102 125 127 126 126 126 126 126 126 127 127 127 127 128 129

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?